New Role for Olaparib in BRCA Ovarian Cancer in Neoadjuvant Setting
Administering olaparib in the neoadjuvant setting resulted in favorable surgical options, manageable adverse events, and positive health outcomes in women with ovarian cancer and germline mutations.